We are live on ! Find out more
STXS icon

Stereotaxis

71 hedge funds and large institutions have $64.9M invested in Stereotaxis in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.73% less ownership

Funds ownership: 49.02%48.28% (-0.73%)

3% less capital invested

Capital invested by funds: $67.2M → $64.9M (-$2.28M)

16% less funds holding

Funds holding: 8571 (-14)

25% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 24

78% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 18

Holders
71
Holders Change
-14
Holders Change %
-16.47%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
4
Increased
18
Reduced
24
Closed
18
Calls
$212K
Puts
Net Calls
+$212K
Net Calls Change
-$1K

STXS Hedge Fund Activity: Q3 2022 in Review

71 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Stereotaxis (STXS) for Q3 2022, worth a combined $64.9M — down 3.4% from $67.2M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of STXS and 4 opened new positions — a net loss of 14 holders — while 24 trimmed existing stakes and 18 added.

The largest buyer was Lagoda Investment Management, adding an estimated $1.21M. The largest seller was Opaleye Management, cutting an estimated $1.16M.

  • 71 institutional investors held Stereotaxis (STXS) as of Q3 2022, down from 85 in Q2 2022.
  • Funds reported $64.9M of Stereotaxis stock for Q3 2022, down 3.4% quarter-over-quarter.
  • 4 funds opened new Stereotaxis positions in Q3 2022 and 18 closed out, a net change of -14 holders.
  • The largest Stereotaxis buyer in Q3 2022 was Lagoda Investment Management, an estimated $1.21M added.
  • The largest Stereotaxis seller in Q3 2022 was Opaleye Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q3 2022.